Delivery Order SPE2DB22D1103-SPE2DB24FTGJ8
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $132,002.22 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp. for the supply of 4,565,427,049 units of Eliquis 5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,743.83 contract is for the supply of 60 tablets of the prescription drug Eliquis 5 mg, with a completion date of March 7, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,008,777 tablets of Eliquis 5 mg. The $3,061.31 contract has a performance period through March 20, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp also holds a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Eliquis 5 mg tablets. The $7,295.22 contract has a completion date of February 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $16,544.69 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets and has an ultimate completion date of January 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,170,509 tablets of Eliquis 5 mg. The $20,225.53 award has an ultimate completion date of April 5, 2024. This delivery order is part of a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp that serves as the primary vehicle for the company to deliver pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,119.95 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of Eliquis 5 mg tablets and has a performance period through March 13, 2024. AmerisourceBergen Drug Corp is the prime contractor on this order, which was not set aside under any socioeconomic programs. Additionally, AmerisourceBergen Drug Corp holds an Indefinite Delivery...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,065.21 firm fixed price delivery order contract (SPE2DX15D3504|SPE2DX24F05K0) for the supply of ELIQUIS 5 MG TABLET 60S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order for $1,187.55 to supply 60 tablets of Eliquis 2.5 mg. This order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,119,216 units of the pharmaceutical product Eliquis 5 mg tablets. The contract has a ceiling value of $21,176.18 and a period of performance through April 1, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued at up to...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTGJ8Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. This $9,313.70 contract is for the delivery of 4,563,926,216 units of the medication Eliquis 5 mg tablets. The contract has an ultimate completion date of March 12, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This serves as the primary vehicle for AmerisourceBergen to provide pharmaceutical products and medical supplies to military treatment facilities worldwide in support of the Department of Defense. Firm fixed price task orders, like the one awarded here, enable the delivery of a comprehensive range of medications and healthcare materials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 3/11/24 |